Hostname: page-component-5c6d5d7d68-txr5j Total loading time: 0 Render date: 2024-08-27T12:37:29.407Z Has data issue: false hasContentIssue false

Are we braver today in using antidepressants perinatally?- own clinical experiences

Published online by Cambridge University Press:  27 August 2024

K. Matić
Affiliation:
1University Psychiatric Clinic Sveti Ivan, Zagreb
S. Vuk Pisk*
Affiliation:
1University Psychiatric Clinic Sveti Ivan, Zagreb 2Faculty of Dental Medicine and Health, Osijek
E. Ivezić
Affiliation:
1University Psychiatric Clinic Sveti Ivan, Zagreb 3Faculty of Dental Medicine and Health
V. Grošić
Affiliation:
1University Psychiatric Clinic Sveti Ivan, Zagreb 2Faculty of Dental Medicine and Health, Osijek
I. Filipčić
Affiliation:
1University Psychiatric Clinic Sveti Ivan, Zagreb 3Faculty of Dental Medicine and Health 4University of Zagreb School of medicine, Zagreb, Croatia
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Affective disorders are among the most common mental health problems in women of reproductive age. A life-changing condition, such as pregnancy, may trigger or intensify symptoms of affective disorders, rather than pregnancy being a protective factor for the development of the disorder, as previously thought. Previous research indicates that 18% of women suffer from perinatal depression. One in 7-10 pregnant women and 1 in 5-8 midwives develops a depressive disorder, which is more than half a million women a year. Untreated perinatal depression has significant repercussions for both mother and child. Given that there are no controlled randomized studies during pregnancy, and the results of previous research on the harmfulness of the use of psychotropic drugs are contradictory, we need to nurture an individualized and integrative approach to the use of psychotropic drugs in pregnant women and in the postpartum period. The goal of this lecture is to point out the necessity of treating perinatal depressive disorder with an emphasis on the need to work on dilemmas and selected sources of information by pregnant women themselves, as well as health professionals. In the end, I must emphasize the importance of choosing an adequate psychopharmaceutical in that sensitive period for a woman, nurturing an individual approach as well as the latest knowledge.

Objectives

The aim of this research is to examine the attitudes of psychiatrists, GP doctors, gynecologists and pregnant women about prescribing and taking pharmacotherapy during pregnancy.

Methods

The research will be conducted at the psychiatry clinic, the gynecology clinic and in health centers through semi-structured questionnaires, which will be filled out by psychiatrists, gynecologists, doctors and pregnant women.

Results

Preliminary results (given that the research is still ongoing) indicate that most psychiatrists avoid prescribing drugs during pregnancy, and if they decide to do so, then diazepam is prescribed. The views of gynecologists, family medicine doctors and pregnant women are still pending.

Conclusions

This lecture aims to point out the factors contributing to the fear of prescribing psychotropic drugs perinatally, based on our own research, which included psychiatrists, gynecologists, family medicine doctors, and pregnant women.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.